Skip to content

The Timing of Goniosynechialysis in Treatment of Primary Angle-Closure Glaucoma Combined with Cataract

The Timing of Goniosynechialysis in Treatment of Primary Angle-Closure Glaucoma Combined with Cataract

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002368
Enrollment
Unknown
Registered
2012-06-21
Start date
2010-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary angle-closure glaucoma combined with cataract

Interventions

A:did GSL before PHACO
B:did GSL after PHACO

Sponsors

Department of Ophthalmology, Research Institute of Surgery & Daping Hospital, Third Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria were as follows: 1. Occludable angle confirmed by gonioscopy (OMVGLF-1.5X): the gonioscope examinations were carried out in a darkened room with minimum-possible slit-lamp illumination, making sure that the slit beam did not impinge upon the pupil(6). The extent of posterior goniosynechia of the included patient was one-third to three-quarters; 2. Evidence was found of uncontrolled IOP (raised IOP, progressive glaucomatous optic neuropathy, and/or visual field progression); 3. All patients conformed to the diagnose standard of angle-closure glaucoma proposed by Foster in 2002(7): people meeting gonioscopic criteria for narrow angles and with evidence of significant obstruction of the functional trabecular meshwork by the peripheral iris would be classified as having primary angle closure (PAC). Those in whom PAC had led to significant glaucomatous damage to the optic nerve would be defined as having PACG.

Exclusion criteria

Exclusion criteria: Exclusion criteria included: 1. Plateau iris syndrome; 2. Previous glaucoma surgery (argon laser/trabeculoplasty/trabeculectomy); 3. Retinal disease; 4. History of ocular injury; 5. Previous patent PI; 6. Other glaucomas.

Design outcomes

Primary

MeasureTime frame
IOP;visual acuity;the degree of the anterior angle;

Countries

China

Contacts

Public ContactJian Ye
yejian1979@163.com+86 23 68757766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026